News

Demand for obesity drugs shoots up in India as Lilly, Novo jostle for market share
Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly and Novo Nordisk are competing for ...
3 No-Brainer Stocks to Buy in July
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Fancy Weight Loss Drugs Like Ozempic and Mounjaro? Here is Why Skipping a Blood Test Could Be Dangerous
Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or ...
Insurance Business America47m
CVS Caremark removes coverage of Zepbound amid pricing concerns
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
Albert Lea Tribune1h
‘Sticker shock’: Inflation, Ozempic drive health care costs higher for Minnesota schools
By Elizabeth Shockman, MPR News acing a massive increase in employee health insurance rates, leaders at Anoka-Hennepin Area Schools last May asked a question out loud: Should the district stop paying ...